Cardio Diagnostics Holdings, Inc.(CDIO)

Biotechnology · Chicago, IL

$2.06+0.10 (+5.10%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T12:45:54.338Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:45:54.338Z.

Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.06
Unrounded diluted TTM EPS · period ending 2026-06-30: -2.92

FMP input reference: 9b4bc62a31f75b1a016fc6ea0dc71fcb65437a541a8d62a03c8decabfd044c64

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

CDIO PE Ratio Metrics

PE RATIO

N/A

CDIO Competitors' PE Ratio

CDIO

Cardio Diagnostics Holdings, Inc.

Current

Market Cap

$6.10M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FEMY

Femasys Inc.

vs CDIO

Market Cap

$6.10M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENLV

Enlivex Therapeutics Ltd.

vs CDIO

Market Cap

$6.09M

PE Ratio

0.00

TTM Avg

0.02

3Y Avg

0.02

5Y Avg

0.02

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

vs CDIO

Market Cap

$6.03M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMRA

Biomerica, Inc.

vs CDIO

Market Cap

$6.34M

PE Ratio

N/A

TTM Avg

278.25

3Y Avg

163.06

5Y Avg

336.05

ENSC

Ensysce Biosciences, Inc.

vs CDIO

Market Cap

$6.44M

PE Ratio

N/A

TTM Avg

4788.36

3Y Avg

147312.95

5Y Avg

148989.26

ACXP

Acurx Pharmaceuticals, Inc.

vs CDIO

Market Cap

$5.63M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INBS

Intelligent Bio Solutions Inc.

vs CDIO

Market Cap

$5.54M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BOLT

Bolt Biotherapeutics, Inc.

vs CDIO

Market Cap

$6.72M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACON

Aclarion, Inc.

vs CDIO

Market Cap

$6.74M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Cardio Diagnostics Holdings, Inc. (CDIO)	$6.10M	N/A	N/A	N/A	N/A
Femasys Inc. (FEMY)vs ›	$6.10M	N/A	N/A	N/A	N/A
Enlivex Therapeutics Ltd. (ENLV)vs ›	$6.09M	0.00	0.02	0.02	0.02
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$6.03M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.34M	N/A	278.25	163.06	336.05
Ensysce Biosciences, Inc. (ENSC)vs ›	$6.44M	N/A	4788.36	147312.95	148989.26
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.63M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.54M	N/A	N/A	N/A	N/A
Bolt Biotherapeutics, Inc. (BOLT)vs ›	$6.72M	N/A	N/A	N/A	N/A
Aclarion, Inc. (ACON)vs ›	$6.74M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.06

Forward EPS (Est.)

$-16.50

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

CDIO PE Ratio Metrics

CDIO Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics